PMID- 36518258
OWN - NLM
STAT- MEDLINE
DCOM- 20221216
LR  - 20230126
IS  - 1664-2392 (Print)
IS  - 1664-2392 (Electronic)
IS  - 1664-2392 (Linking)
VI  - 13
DP  - 2022
TI  - Exploring risk factors of short-term readmission in heart failure patients: A 
      cohort study.
PG  - 1024759
LID - 10.3389/fendo.2022.1024759 [doi]
LID - 1024759
AB  - BACKGROUND: The risk of all-cause mortality in patients with heart failure (HF) 
      has been studied previously. Readmission risk of HF patients was rarely explored. 
      Thus, we aimed to explore early warning factors that may influence short-term 
      readmission of HF patients. METHODS: The data of this study came from an HF 
      database in China. It was a retrospective single-center observational study that 
      collected characteristic data on Chinese HF patients by integrating electronic 
      medical records and follow-up outcome data. Eventually, 1,727 patients with HF 
      were finally included in our study. RESULTS: In our study, the proportion of HF 
      patients with New York Heart Association (NYHA) class II, III, and IV HF were 
      17.20%, 52.69%, and 30.11%, respectively. The proportion of patients with 
      readmission within 6 months and readmission within 3 months was 38.33% and 
      24.20%, respectively. Multivariate logistic regression showed that NYHA class (p 
      (III) = 0.028, p (IV) < 0.001), diabetes (p = 0.002), Cr (p = 0.003), and RDW-SD 
      (p = 0.039) were risk factors for readmission within 6 months of HF patients. 
      NYHA class (p (III) = 0.038, p (IV) < 0.001), CCI (p = 0.033), Cr (p = 0.012), UA 
      (p = 0.042), and Na (p = 0.026) were risk factors for readmission within 3 months 
      of HF patients. CONCLUSIONS: Our study implied risk factors of short-term 
      readmission risk in patients with HF, which may provide policy guidance for the 
      prognosis of patients with HF.
CI  - Copyright (c) 2022 Niu, Wen, Sun, Zhao, Wang and Li.
FAU - Niu, Xiao Na
AU  - Niu XN
AD  - Department of Cardiology, Tangdu Hospital, The Second Affiliated Hospital of Air 
      Force Medical University, Xi'an, China.
FAU - Wen, He
AU  - Wen H
AD  - Department of Cardiology, Tangdu Hospital, The Second Affiliated Hospital of Air 
      Force Medical University, Xi'an, China.
FAU - Sun, Nan
AU  - Sun N
AD  - Department of Cardiology, Tangdu Hospital, The Second Affiliated Hospital of Air 
      Force Medical University, Xi'an, China.
FAU - Zhao, Ran
AU  - Zhao R
AD  - Department of Cardiology, Tangdu Hospital, The Second Affiliated Hospital of Air 
      Force Medical University, Xi'an, China.
FAU - Wang, Ting
AU  - Wang T
AD  - Department of Cardiology, Tangdu Hospital, The Second Affiliated Hospital of Air 
      Force Medical University, Xi'an, China.
FAU - Li, Yan
AU  - Li Y
AD  - Department of Cardiology, Tangdu Hospital, The Second Affiliated Hospital of Air 
      Force Medical University, Xi'an, China.
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20221128
PL  - Switzerland
TA  - Front Endocrinol (Lausanne)
JT  - Frontiers in endocrinology
JID - 101555782
SB  - IM
MH  - Humans
MH  - *Patient Readmission
MH  - Cohort Studies
MH  - Retrospective Studies
MH  - *Heart Failure/epidemiology/therapy/complications
MH  - Risk Factors
PMC - PMC9742544
OTO - NOTNLM
OT  - a cohort study
OT  - heart failure (HF)
OT  - prognosis
OT  - readmission
OT  - risk factors
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/12/16 06:00
MHDA- 2022/12/17 06:00
PMCR- 2022/01/01
CRDT- 2022/12/15 02:18
PHST- 2022/08/22 00:00 [received]
PHST- 2022/11/09 00:00 [accepted]
PHST- 2022/12/15 02:18 [entrez]
PHST- 2022/12/16 06:00 [pubmed]
PHST- 2022/12/17 06:00 [medline]
PHST- 2022/01/01 00:00 [pmc-release]
AID - 10.3389/fendo.2022.1024759 [doi]
PST - epublish
SO  - Front Endocrinol (Lausanne). 2022 Nov 28;13:1024759. doi: 
      10.3389/fendo.2022.1024759. eCollection 2022.